New drug trial offers hope for advanced stomach cancer patients Who've run out of options
Disease control
Not yet recruiting
This study is testing an experimental drug called NB003 for people with advanced gastrointestinal stromal tumors (GIST) that have stopped responding to standard medications. The trial has two parts: one compares NB003 against an existing drug for patients who need third-line trea…
Phase: PHASE2, PHASE3 • Sponsor: Ningbo Newbay Technology Development Co., Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC